Shares of Nuvo Research (TSX:NRI) are up today after the company announced it had reacquired the rights to market osteoarthritis knee pain treatment … [Read more...] about Nuvo Research rises after regaining Pennsaid 2% marketing rights
When it comes to spending money, nobody does it quite like the biotech sector. The Texas Hold-Em style gamble of waiting to see if your particular … [Read more...] about Canada’s Biotech Stocks. Who’s got the Cash?
Canada's Cashed up Tech Stocks, PART THREE. Companies Listed in the TSX, Technology, Cleantech and Life Sciences Sectors with a Market Cap Less Than … [Read more...] about Canada’s Cashed up Tech Stocks; Part Three
Milestone payments can be tricky business for publicly listed biotechs. One one hand, the cash creates a margin of safety for investors. On the other … [Read more...] about Signs of Life at Nuvo Research?
If you are trying to measure how fast a company is growing it is, without doubt, best to take a long view. Revenues can be lumpy and unpredictable, … [Read more...] about Canada’s 10 Fastest Growing Tech Stocks
Mississauga's Nuvo Research, which has developed an osteoarthritis pain-killing cream that is absorbed through the skin, saw its revenues leap on a … [Read more...] about Breaking down the balance sheet of Nuvo Research (TSX:NRI)